| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/23/2008 | CN101108163A Novel technique of preparing lactic acid ciprofloxacin injection |
| 01/23/2008 | CN100363489C An imine-resistant bacillus pyocyaneus bacteriophage and its use for treating infection therefrom |
| 01/23/2008 | CN100363383C Micro-molecular polypeptides capable of combining with gold staphylococcus virulence factor regulatory protein and its pharmaceutical use |
| 01/23/2008 | CN100363375C Novel erythromycin derivatives |
| 01/23/2008 | CN100363353C Antifungal compound and its prepn process and application |
| 01/23/2008 | CN100363346C Small molecular inhibiting agent for coronavirus main proteinase, its preparation method and uses |
| 01/23/2008 | CN100363333C Antifungus compound, its preparation method and application |
| 01/23/2008 | CN100363055C Pharmaceutical compositions for hepatitis C viral protease inhibitors |
| 01/23/2008 | CN100363053C Intracellular isoform of the interleukin-1 receptor antagonist |
| 01/23/2008 | CN100363045C Traditional Chinese medicine and western medicine compositions comprising biphenyldicarboxylate for treating hepatitis accessorily |
| 01/23/2008 | CN100363042C Composition comprising biphenyldicarboxylate |
| 01/23/2008 | CN100363032C Eggplant root extract and its preparing method and use |
| 01/23/2008 | CN100363030C Chinese herbal preparation for killing fungus of fish, shrimp and crab |
| 01/23/2008 | CN100363027C Liver-care composition and its prepn. method |
| 01/23/2008 | CN100363018C Honeysuckle flower soft capsule and preparation method thereof |
| 01/23/2008 | CN100363001C Moxifloxacin capsule and its preparation method |
| 01/23/2008 | CN100362999C Antimicrobial medicinal composition and its production process |
| 01/23/2008 | CN100362990C Fibrauretine-amino acid fluid for transfusion and its production process |
| 01/22/2008 | US7320993 Aryl-substituted pyridylalkane, alkene, and alkine carboxamides useful as cytostatic useful as cytostatic and immuosuppressive agents |
| 01/22/2008 | US7320983 Sulfur compounds such as phenylmethyl [2R-hydroxy-3-[(3-methylbutyl) (phenylsulfonyl)amino]-1S-(phenylmethyl)propyl]carbamate, used for prevention of viral diseases and replication |
| 01/22/2008 | US7320982 Use of 4-substituted tetrahydropyridines for the manufacture of medicaments acting upon TGF-β 1 |
| 01/22/2008 | US7320964 Modulation of expression of STAT-1 dependent genes |
| 01/22/2008 | US7320875 Screening for neutralizing hepatitis C virus antibodies in a blood sample utilizing an HCV E2 protein and a protein from a human or chimpanzee cell that has a molecular weight of 24 kd that binds to the E2 protein of HCV; comparing the amount of bound proteins to that in the absence of HCV antibodies |
| 01/22/2008 | US7320793 Comprises ordered and repetitive antigen or antigenic determinant array for developing vaccines for treatment of infectious diseases, allergies and cancer; microarrays |
| 01/22/2008 | US7320784 Metal support surface, conjugate releasably bound to the support surface, the conjugate comprising a ligand and a targeting molecule;wherein the conjugate coordinates with a complex-forming metal ion so that labeled conjugate is released; radiotherapy and as imaging agents in medical diagnostics |
| 01/22/2008 | CA2468036C A method of treating bacterial infections using gemifloxacin or a salt thereof and a .beta.-lactam antibiotic |
| 01/22/2008 | CA2432884C Nutritional composition with health promoting action containing oligosaccharides |
| 01/22/2008 | CA2392168C Vitamin d analogues |
| 01/22/2008 | CA2368348C Biodegradable, injectable oligomer-polymer composition |
| 01/22/2008 | CA2333322C Nitric oxide synthase inhibitors |
| 01/22/2008 | CA2216150C Epithelial adhesive lactobacilli |
| 01/22/2008 | CA2195419C Immunological activity of rhamnolipids |
| 01/22/2008 | CA2178458C Stable complexes of crosslinked polyvinylpyrrolidone and iodine and method of making the same |
| 01/22/2008 | CA2158576C Methods and compositions for the prevention or treatment of sexually transmitted diseases |
| 01/17/2008 | WO2008008912A1 Antiviral agents |
| 01/17/2008 | WO2008008537A2 Combi) compositions for the treatment of mucormycosis. comprising iron chelator and antifungal agent |
| 01/17/2008 | WO2008008432A2 Substituted chiral fused( 1,2) imidazo (4,5-c) ring compounds and methods |
| 01/17/2008 | WO2008007999A1 Anti-tumoral, antibacterial and antiviral pharmaceutical composition (variants) |
| 01/17/2008 | WO2008007935A1 Substance for treating infectious diseases in animals, including humans, and method for obtaining same |
| 01/17/2008 | WO2008007804A1 ANTIHUMAN α9 INTEGRIN ANTIBODY AND USE OF THE SAME |
| 01/17/2008 | WO2008007104A1 Use of tylvalosin as antiviral agent |
| 01/17/2008 | WO2008006979A2 Process for preparing diaminophenothiazinium compounds |
| 01/17/2008 | WO2008006648A1 Substituted 1-methyl-1h-quinolin-2-ones and 1-methyl-1h-1,5-naphthyridin-2-ones as antibacterials |
| 01/17/2008 | WO2008006298A1 Novel crystal form of doripenem, preparation method and uses thereof |
| 01/17/2008 | WO2008006168A1 Treatment of excessive neovascularization |
| 01/17/2008 | WO2007130616A3 Polyamides for treating human papilloma virus |
| 01/17/2008 | WO2007084413B1 Methods for treating hepatitis c |
| 01/17/2008 | WO2007053696A3 Rnai inhibition of influenza virus replication |
| 01/17/2008 | WO2007016476A3 Hepatitis c serine protease inhibitors and uses therefor |
| 01/17/2008 | US20080015343 Azithromycin dosage forms with reduced side effects |
| 01/17/2008 | US20080015340 Fusion protein of antigens from parainfluenza virus (PIV) and respiratory syncytial virus (RSV); single recombinant immunogen can protect susceptible individuals against diseases caused by both PIV and RSV |
| 01/17/2008 | US20080015255 Pharmaceutical Compositions Based on Fluorinated Sulphamides and Sulphinimides |
| 01/17/2008 | US20080015193 Certain azoles exhibiting ATP-utilizing enzyme inhibitory activity, compositions, and uses thereof |
| 01/17/2008 | US20080015189 Antimicrobial photoinactivation using chalcogen analogs of benzo(A)phenoxazinium dyes |
| 01/17/2008 | US20080015187 Hiv Integrase Inhibitors |
| 01/17/2008 | US20080015185 N-heterocyclic inhibitors of tnf-alpha expression |
| 01/17/2008 | US20080015184 Urea Substituted Imidazopyridines, Imidazoquinolines, and Imidazonaphthyridines |
| 01/17/2008 | US20080015183 Substituted quinazolin-4-ylamine analogues |
| 01/17/2008 | US20080015182 Potent PARP Inhibitors |
| 01/17/2008 | US20080015175 Nontoxic; inhibition of interleukin-1 beta -converting enzyme |
| 01/17/2008 | US20080015172 Caspase inhibitors and uses thereof |
| 01/17/2008 | US20080015169 Amino-methyl substituted tetracycline compounds |
| 01/17/2008 | US20080015159 Small Synthetic Rna, a Method of Preparing the Same and Uses Thereof |
| 01/17/2008 | US20080015157 Novel Water-Soluble Prodrugs |
| 01/17/2008 | US20080015156 Novel 2-substituted methyl penam derivatives |
| 01/17/2008 | US20080015153 Pharmaceutical compositions containing the long pentraxin PTX3 |
| 01/17/2008 | US20080015152 Therapeutic amino acid sequences for use in treatment and prevention of viral, infectious, cancerous, diabetic, incontinent, hypertensive, eating and nervous system disorders |
| 01/17/2008 | US20080015146 e.g. 3-Amino-1-[(S)-2-(3-tert-butyl-[1,2,4]oxadiazol-5-yl)-pyrrolidin-1-yl]-4-(2,4,5-trifluorophenyl)-butan-1-one; dipeptidyl-peptidase inhibitor; antidiabetic, hypoglycemic agent; metabolic disorders, obesity, non-insulin dependent diabetes |
| 01/17/2008 | US20080014292 Composition for treating and/or preventing periodontal disease |
| 01/17/2008 | US20080014278 Metal-containing formulations and methods of use |
| 01/17/2008 | US20080014256 having at least one enteric coating; oral bioavailability |
| 01/17/2008 | US20080014252 Topical compositions with long lasting effect |
| 01/17/2008 | US20080014246 Methods and compounds for controlled release of recombinant parvovirus vectors |
| 01/17/2008 | US20080014219 Method of immunization against the 4 dengue serotypes |
| 01/17/2008 | US20080014217 Influenza vaccine |
| 01/17/2008 | US20080014204 Compositions Against Sars-Coronavirus and Uses Thereof |
| 01/17/2008 | US20080014178 Method for Stimulating Mammalian Cells and Mammalian Cell |
| 01/17/2008 | US20080014174 Method for treating tumors, infectious diseases, and autoimmune diseases with an activated HLA matching donor-originating lymphocyte |
| 01/17/2008 | US20080014150 Compositions and method for treating precancerous virus infection and prevention of cancer |
| 01/17/2008 | DE4215677B4 Pharmazeutisches Mittel The pharmaceutical agent |
| 01/17/2008 | DE19907485B4 Virus-Vakzine Virus vaccine |
| 01/17/2008 | DE102006032326A1 Verwendung von Extrakten aus Pelargonium sidoides und/oder Pelargonium reniforme sowie diese Extrakte enthaltende Mittel und pharmazeutische Formulierungen Use of extracts from Pelargonium sidoides and / or Pelargonium reniforme and these extracts compositions containing them and pharmaceutical formulations |
| 01/17/2008 | DE102006032233A1 Use of a preparation containing eucalyptol/menthol for the production of medicament for combating and preventing virus infection and secondary bacterial infection |
| 01/17/2008 | CA2657651A1 Antiviral agents |
| 01/17/2008 | CA2657535A1 Process for preparing diaminophenothiazinium compounds |
| 01/17/2008 | CA2657308A1 Treatment of excessive neovascularization |
| 01/17/2008 | CA2657275A1 Use of tylvalosin as antiviral agent |
| 01/17/2008 | CA2657133A1 Anti-human .alpha.9 integrin antibody and use of the same |
| 01/17/2008 | CA2583555A1 Influenza vaccine |
| 01/16/2008 | EP1878742A2 HIV peptides, antigens, vaccine compositions, immunoassay and a method of detecting antibodies induced by HIV |
| 01/16/2008 | EP1878720A1 Process for preparing chiral bicycloprolinates as intermediates for the preparation of peptidomimetic protease inhibitors |
| 01/16/2008 | EP1878441A2 Complement pathway inhibitors binding to C5 and C5a without preventing the formation of C5b |
| 01/16/2008 | EP1878438A2 Ligand/llytic peptide compositions and methods of use |
| 01/16/2008 | EP1878434A1 Use of extracts from pelargonium sidoides and/or pelargonium reniforms for manufacturing preparations and preparations containing these extracts |
| 01/16/2008 | EP1878432A1 Single dose fast dissolving azithromycin |
| 01/16/2008 | EP1878424A2 Novel vaccine |
| 01/16/2008 | EP1877566A1 Enzymatic production of peracids using perhydrolytic enzymes |
| 01/16/2008 | EP1877539A1 Mutant f. tularensis strain and uses thereof |
| 01/16/2008 | EP1877434A2 Modified interferon-gamma polypeptides and methods for using modified interferon-gamma polypeptides |
| 01/16/2008 | EP1877411A2 Diaryl-purine, azapurines and -deazapurines as non-nucleoside reverse transcriptase inhibitors for treatment of hiv |